Lead consulting of a new factory for highly potent pharmaceuticals
Founded in 1848, Pfizer is the world's largest research pharmaceutical manufacturers, working in human pharmaceuticals and animal health sectors. With 87,000 employees in more than 80 countries, the company generates an annual turnover of almost 50 billion US dollars. Each year, Pfizer Manufacturing Deutschland GmbH at Illertissen produces more than 80 million packs of solid and liquid human pharmaceuticals. One of its core competences is processing highly active substances. The smoking cessation agent Chantix® is also produced here.
By building the new production plant, Pfizer is also contributing to securing the company's economic future. Maximum quality and supreme efficiency are required. A new solids production facility for processing highly potent pharmaceuticals was to be implemented at the Illertissen site.
io-consultants' task, as a lead consultant, has been to fully implement the new factory.
The services provided included conceptual design, structuring of processes, equipment specification, architectural planning, structural analysis and MEP, IT and automation strategies, construction supervision, project management, start-up management and qualification. Highest process automation and online PAT technologies make the new NEWCON production site at Illertissen a benchmark facility.